Cargando…
Chemotherapeutic errors in hospitalised cancer patients: attributable damage and extra costs
BACKGROUND: In spite of increasing efforts to enhance patient safety, medication errors in hospitalised patients are still relatively common, but with potentially severe consequences. This study aimed to assess antineoplastic medication errors in both affected patients and intercepted cases in terms...
Autores principales: | Ranchon, Florence, Salles, Gilles, Späth, Hans-Martin, Schwiertz, Vérane, Vantard, Nicolas, Parat, Stéphanie, Broussais, Florence, You, Benoît, Tartas, Sophie, Souquet, Pierre Jean, Dussart, Claude, Falandry, Claire, Henin, Emilie, Freyer, Gilles, Rioufol, Catherine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262863/ https://www.ncbi.nlm.nih.gov/pubmed/22067636 http://dx.doi.org/10.1186/1471-2407-11-478 |
Ejemplares similares
-
Hypersensitivity to oxaliplatin: clinical features and risk factors
por: Parel, Marie, et al.
Publicado: (2014) -
Immunomodulatory drugs in multiple myeloma: Impact of the SCARMET (Self CARe and MEdication Toxicity) educational intervention on outpatients’ knowledge to manage adverse effects
por: Périchou, Juliette, et al.
Publicado: (2020) -
Pandémie à SARS-COV-2 : implication du pharmacien hospitalier dans la sécurisation de la prise en charge des patients
por: Baudouin, Amandine, et al.
Publicado: (2023) -
Adherence to oral anticancer chemotherapy: What influences patients’ over or non-adherence? Analysis of the OCTO study through quantitative–qualitative methods
por: Bourmaud, Aurélie, et al.
Publicado: (2015) -
Subcutaneous trastuzumab: development of a new formulation for treatment of HER2-positive early breast cancer
por: Hamizi, Salima, et al.
Publicado: (2013)